Table:
begin	end	state
1	16	cytoplasmic
17	40	transmembrane
41	75	non-cytoplasmic
76	96	transmembrane
97	104	cytoplasmic
105	130	transmembrane
131	135	non-cytoplasmic
136	154	transmembrane
155	165	cytoplasmic
166	190	transmembrane
191	209	non-cytoplasmic
210	229	transmembrane
230	256	cytoplasmic
257	284	transmembrane
285	297	non-cytoplasmic
298	318	transmembrane
319	328	cytoplasmic
329	346	transmembrane
347	353	non-cytoplasmic

Input:
>WP_008632109.1 NCBI__GCF_000330725.2:WP_008632109.1
MTVNTISQTKTELQAKVLLGLGVGLLVLAFLSLSVGAFSIPLGNVLSIISSQLGVNFADF
TAQQSNVLLQIRLPRLLLAILVGGGLGITGASLQGLFRNPLVEPGLIGVSTGGALFAVIF
IVFGASIPAWHYLGPFALPLAAFIGGLLNTYIVYRIASQFGKTDISLLILSGVALNALSG
ALIGLVLFYADDAAIRNFTFWSLGDLGGANWTKVGIGFLLIVGPVVFLLSQFRNLNALAI
GENEAFHMGVDVQKTKIILLVASAVIVGTAVSMSGTIGFVGLVVPHLLRLTFGADHRLIL
PGSFLLGAILLTGADILARTIVMPAEMPIGIITAIMGAPFFVWLILRFKKIRY

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server